Infertility and Mental Health: How Common Distress Actually Is

Common enough that it is closer to the norm than the exception. A meta-analysis of psychological problems during assisted reproductive treatment reported pooled prevalence of anxiety symptoms at 48.0% among infertile women, with a 95% confidence interval of 36.6% to 59.9%.

Depression symptoms were reported at 35.6% (95% CI 28.0% to 43.3%). Earlier meta-analyses put anxiety somewhere between 25% and 54%, and depression between 28% and 44% — wide ranges that still sit far above the general population.

• Anxiety symptoms: pooled prevalence 48.0% in infertile women.
• Depression symptoms: pooled prevalence 35.6%.
• In men: anxiety 28.4%, depression 18.6%.
• Women report higher rates than men across these measures.

The reason to state numbers rather than sympathy is that people going through this routinely believe they are coping worse than everyone else. The data say otherwise.

Because the studies underneath measure different things in different populations with different instruments. A confidence interval running from 36.6% to 59.9% is wide for a reason, and the reason is heterogeneity rather than sloppiness.

Screening tools detect symptoms, not diagnoses. A prevalence of 48% for anxiety symptoms does not mean 48% have an anxiety disorder — it means roughly half score above a threshold on a questionnaire.

• Different instruments have different thresholds.
• Populations vary — treatment stage, duration, cause.
• Symptom prevalence is not the same as diagnosis.
• Wide intervals mean the true figure is uncertain, not fabricated.

None of that undermines the finding. Across every instrument and population, rates sit well above what would be expected in people not going through this.

• Supporting a Partner Through IVF: What Actually Helps
• Fertility Myths vs Facts: Ten Claims Checked Against the Evidence
• How Common Is Infertility? What the WHO Data Actually Show
• TSH and Fertility — What Your Thyroid Result Actually Means (India 2026)
• IVF With Endometrial Polyps — Does It Need Removing First? (2026)
• GnRH Antagonist vs Agonist Protocol — Which IVF Protocol, and Why (2026)
• What Is Assisted Hatching — And Does the Evidence Support It? (2026)

Usually, and the figures show why that is a mistake. Pooled prevalence of anxiety in infertile men was 28.4% and depression 18.6% — lower than in women, but far from negligible.

Men are also less likely to be asked. Clinical contact in fertility care is concentrated on the woman even when the cause is male factor, so distress in the partner tends to go unmeasured as well as unaddressed.

• Anxiety in infertile men: pooled prevalence 28.4%.
• Depression: 18.6%.
• Men have fewer clinical touchpoints where distress might be noticed.
• Male-factor diagnoses carry their own particular difficulty.

A practical consequence is that support offered to one partner should not be assumed to reach the other. They are usually attending different appointments and hearing different amounts.

Being treated for distress because it matters, rather than as a fertility intervention. This distinction is worth being firm about: managing anxiety or depression is justified on its own terms.

• Counseling, ideally from someone familiar with fertility care.
• Treatment for depression or anxiety where it is present.
• Clear information, which reduces the uncertainty doing much of the damage.
• Support that includes the partner, not only the patient.

Routine psychological assessment is recommended in some groups, including women with PCOS and those with recurrent pregnancy loss, on the basis that early identification helps.

What the evidence does not support is presenting psychological treatment as a way of improving your chance of a baby. No stress-reduction program has been shown to raise live birth rates — a point covered in our article on stress and infertility. Being told your distress is costing you a pregnancy adds harm without evidence.

Practical support matters as much as psychological support, and is easier to arrange. Knowing what a result means, what the next step is, and what the realistic range of outcomes looks like removes a substantial amount of the load — because much of the distress in fertility care is uncertainty rather than bad news.

It is also reasonable to set limits on how much of your life this occupies. People commonly describe treatment expanding to fill everything, and deciding in advance how many cycles, over what period, and with what point of review is a way of keeping a decision from being made by exhaustion instead.

One more thing worth saying plainly, because the prevalence figures point straight at it: if roughly half of women in these studies score above threshold for anxiety, then the reaction you are having is the expected one. Reading your own distress as evidence that you are handling this badly is a conclusion the data do not support.